Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men.

摘要: Trans-rectal ultrasound guided biopsy of the prostate represents diagnostic standard for cancer, but its mortality rate has never been examined. We performed a population-based study 120-day after in 22,175 patients, who underwent between 1989 and 2000. The control group consisted 1,778 men aged 65–85 years (median 69.5), did not undergo biopsy. Univariable multivariable logistic regression analyses were 11,087 (50%) subjected to biopsy, identify predictors mortality. Variables age at baseline Charlson comorbidity index cumulative number procedures. externally validated model's remaining 50% men. Overall was 1.3% versus 0.3% (p < 0.001) group. Of ≤60 years, 0.2% died within 120 days 2.5% 76–80. Zero score yielded 0.7% 2.2%, if 3–4. First ever procedures carried higher risk than subsequent (1.4 vs. 0.8 0.6%). In model, first increasing predicted Overall, variables 79% accurate predicting probability conclusion, our data suggest that might predispose rate. certainty this association remains be proven. © 2008 Wiley-Liss, Inc.